Sanofi recalls popular heartburn drug Zantac as FDA investigates probable carcinogen
Sanofi said Friday it will recall the widely-used heartburn drug Zantac from stores in the United States and Canada as the drugmaker and Food and Drug Administration investigate a probable carcinogen detected in the drug. The FDA last month said it...